| For: | Yu SM, Zheng HC, Wang SC, Rong WY, Li P, Jing J, He TT, Li JH, Ding X, Wang RL. Salivary metabolites are promising noninvasive biomarkers of drug-induced liver injury. World J Gastroenterol 2024; 30(18): 2454-2466 [PMID: 38764769 DOI: 10.3748/wjg.v30.i18.2454] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i18/2454.htm |
| Number | Citing Articles |
| 1 |
Hao Niu, Ismael Alvarez‐Alvarez, Minjun Chen. Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury. Liver International 2025; 45(3) doi: 10.1111/liv.70038
|
| 2 |
Xinyuan Zhao, Xu Chen, Zihao Zhou, Jiarong Zheng, Yunfan Lin, Yucheng Zheng, Rongwei Xu, Shen Hu, Li Cui. Advancements and Challenges in Salivary Metabolomics for Early Detection and Monitoring of Systemic Diseases. MedComm 2025; 6(10) doi: 10.1002/mco2.70395
|
| 3 |
Zhikun Wang, Linqian Wu, Ke Bai, Mengru Qiu, Qing Li, Liangtao Zeng, Yipeng Wan, Hui Zhu, Lifang Chen, Zhili Wen, Lingling Yang. Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective study. Clinics and Research in Hepatology and Gastroenterology 2026; 50(1): 102747 doi: 10.1016/j.clinre.2025.102747
|
| 4 |
Jun Pu, Yamin Zhao, Siming Zhang, Tianqi Wu, Ruizi Liu, Tianyi Yuan, Songnian He, Qingyu Hao, Haixia Zhu. Mapping the knowledge domains of literature on hepatocellular carcinoma and liver failure: a bibliometric approach. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1529297
|
